Osseon Revenue and Competitors
Estimated Revenue & Valuation
- Osseon's estimated annual revenue is currently $6.5M per year.
- Osseon's estimated revenue per employee is $251,000
Employee Data
- Osseon has 26 Employees.
- Osseon grew their employee count by -7% last year.
Osseon's People
Name | Title | Email/Phone |
---|
Osseon Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Osseon?
Osseon's goal is to improve the quality of life for patients and to provide healthcare professionals with innovative treatment options for compression fractures within the thoracic and lumbar vertebral spine. Osseon develops, markets, and distributes minimally invasive devices for the treatment of vertebral compression fractures. Headquartered in Santa Rosa, CA, the company's patented steerable technology and delivery systems provide safe and effective solutions, while offering significant advantages in efficiency and cost. Osseon products are distributed worldwide.
keywords:N/AN/A
Total Funding
26
Number of Employees
$6.5M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Osseon News
Osseon LLC. 10.5. Alphatec Spine, Inc. 10.6. TAEYEON MEDICAL Co., Ltd. 10.7. G-21 s.r.l.. 10.8. BMK Global Medical Company.
10.2. Stryker Corporation. 10.3. CareFusion Corporation. 10.4. Osseon LLC. 10.5. Alphatec Spine, Inc. 10.6. TAEYEON MEDICAL Co., Ltd. 10.7.
... Zimmer Biomet, DePuy Synthes (Johnson & Johnson), DJO, Smith & Nephew, Teknimed, aap Implantate AG, Tecres (IT), Medacta, Osseon.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.6M | 26 | 4% | N/A |
#2 | $3.2M | 26 | 4% | N/A |
#3 | $3.5M | 26 | -26% | N/A |
#4 | $4.6M | 26 | -4% | N/A |
#5 | N/A | 26 | 8% | N/A |